Abigail Scott
Payments from drug & device makers
Across 88 payments — averaging $18.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$268
- AbbVie$252
- Otsuka America Pharmaceutical, Inc.$174
- AstraZeneca$149
- Boehringer Ingelheim$124
- Pfizer$91
- plus $601 from 20 others
What the payments were for
- Food & beverage$1,657100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 13 | $268 |
| AbbVie | 13 | $252 |
| Otsuka America Pharmaceutical, Inc. | 8 | $174 |
| AstraZeneca | 9 | $149 |
| Boehringer Ingelheim | 6 | $124 |
| Pfizer | 6 | $91 |
| GSK | 4 | $78 |
| Dexcom, Inc. | 3 | $68 |
| Lilly USA, LLC | 4 | $68 |
| Corium, LLC | 2 | $43 |
| Lundbeck LLC | 2 | $41 |
| Astellas Pharma US Inc | 2 | $34 |
| Exact Sciences | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Nevro Corp. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Bayer | 1 | $15 |
| Verona Pharma, Inc. | 1 | $15 |
| Cranial Technologies, Inc | 1 | $15 |
| Amgen | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $12 |
How this compares
$1,657 in reported general payments places this provider in the 75th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 62 | $69,394 |
| RexultiBrexpiprazole | 13 | $51,978 |
| RybelsusSemaglutide | 25 | $26,881 |
| EliquisApixaban | 25 | $22,665 |
| XareltoRivaroxaban | 17 | $22,439 |
| TrulicityDulaglutide | 17 | $20,869 |
| MounjaroTirzepatide | 18 | $20,436 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $18,162 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $17,308 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 19 | $17,080 |
| Spiriva RespimatTiotropium Bromide | 15 | $11,559 |
| TrintellixVortioxetine Hydrobromide | 11 | $5,159 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 81 | $3,516 |
| Atorvastatin Calcium | 192 | $3,263 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $1,875 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $268 | $96,27587 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $174 | $51,97813 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $68 | $41,30535 claims |
| PfizerEliquis | $91 | $22,66525 claims |
| GSKTrelegy Ellipta | $78 | $17,30812 claims |
| Boehringer IngelheimSpiriva Respimat | $124 | $11,55915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,657 family providers in Michigan.
Other family in Ionia
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.